Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Male Infertility (FITMI)
NCT05212337Phase 2Active, not recruiting
- Start
- Jan 2022
- Primary completion
- Oct 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in male infertility. Started Jan 2022; status: active, not recruiting.
02
Drugs
denosumab
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT05212337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05212337.